Effects of aldose reductase inhibitor in diabetic rats

被引：0

作者：

Nagai, T ^{[1
]}

Sekizuka, E ^{[1
]}

Tsukada, K ^{[1
]}

Shimizu, T ^{[1
]}

Minamitani, H ^{[1
]}

Hokari, R ^{[1
]}

Oshio, C ^{[1
]}

机构：

[1] Keio Univ, Fac Sci & Technol, Inst Biomed Engn, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan

来源：

PROCEEDINGS OF THE 20TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOL 20, PTS 1-6: BIOMEDICAL ENGINEERING TOWARDS THE YEAR 2000 AND BEYOND | 1998年 / 20卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

In microcirculation, RBC deformability is one of the most important factor. In this study, the effect of aldose reductase inhibitor (ARI) on RBC deformability in diabetic rats was investigated. Seven-week-old Wistar male rats were used as a diabetic model. We injected streptozotocin (STZ) (55mg/kg) intraperitoneally to make them diabetic. And then we administered ARI orally to the STZ rats. We classified them into STZ injected diabetic group (DM) and STZ and ARI treated diabetic group (ARI). Experiments were performed three weeks after STZ treatment. The RBC deformability was measured directly from the microscope images of mesentery. From this experiment, it was found that ARI didn't alter HbA1c, but improved the decreased RBC deformability in diabetes to the normal level.

引用

页码：3098 / 3099

页数：2

共 50 条

[1] EFFECTS OF A NEW ALDOSE REDUCTASE INHIBITOR ON DIABETIC COMPLICATIONS IN RATS
GERVASI, GB
BARTOLI, C
CATALANI, R
FARINA, C
CARPITA, G
CACCIA, G
AMMANNATI, P
[J]. ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1991, 41-2 (11): : 1160 - 1163
[2] THE EFFECTS OF A NEW ALDOSE REDUCTASE INHIBITOR (TOLRESTAT) IN GALACTOSEMIC AND DIABETIC RATS
SIMARDDUQUESNE, N
GRESELIN, E
DUBUC, J
DVORNIK, D
[J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1985, 34 (10): : 885 - 892
[3] Effects of an aldose reductase inhibitor on gastroenteropathy in streptozotocin-diabetic rats
Oya, M
Hosokawa, M
Tsukada, H
Fukuda, K
Nakamura, H
Tsukiyama, K
Nagashima, K
Fujimoto, S
Yamada, Y
Semo, Y
[J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2003, 62 (02) : 69 - 77
[4] THE EFFECTS OF ALDOSE REDUCTASE INHIBITOR ON THE CORNEAL ENDOTHELIAL MORPHOLOGY IN DIABETIC RATS
MATSUDA, M
AWATA, T
OHASHI, Y
INABA, M
FUKUDA, M
MANABE, R
[J]. CURRENT EYE RESEARCH, 1987, 6 (02) : 391 - 397
[5] EFFECTS OF ALDOSE REDUCTASE INHIBITOR ON RETINAL MICROANGIOPATHY IN STREPTOZOTOCIN-DIABETIC RATS
KOJIMA, K
MATSUBARA, H
HARADA, T
MIZUNO, K
SUZUKI, M
HOTTA, N
KAKUTA, H
SAKAMOTO, N
[J]. JAPANESE JOURNAL OF OPHTHALMOLOGY, 1985, 29 (01) : 99 - 109
[6] Neuropathy in diabetic mice overexpressing human aldose reductase and effects of aldose reductase inhibitor
Yagihashi, S
Yamagishi, SI
Wada, R
Baba, M
Hohman, TC
Yabe-Nishimura, C
Kokai, Y
[J]. BRAIN, 2001, 124 : 2448 - 2458
[7] REVERSAL OF ALBUMINURIA IN DIABETIC RATS BY ALDOSE REDUCTASE INHIBITOR ZOPOLRESTAT
ELLERY, C
OATES, P
[J]. DIABETES, 1994, 43 : A204 - A204
[8] THE EFFECT OF AN ALDOSE REDUCTASE INHIBITOR (EPALRESTAT) ON DIABETIC NEPHROPATHY IN RATS
ITAGAKI, I
SHIMIZU, K
KAMANAKA, Y
EBATA, K
KIKKAWA, R
HANEDA, M
SHIGETA, Y
[J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 1994, 25 (03) : 147 - 154
[9] The effects of zenarestat, an aldose reductase inhibitor, on peripheral neuropathy in Zucker diabetic fatty rats
Shimoshige, Y
Ikuma, K
Yamamoto, T
Takakura, S
Kawamura, I
Seki, J
Mutoh, S
Goto, T
[J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2000, 49 (11): : 1395 - 1399
[10] EFFECTS OF AN ALDOSE REDUCTASE INHIBITOR, SORBINIL, ON EXPERIMENTAL DIABETIC NEUROPATHY AND SUGAR CATARACTS IN RATS
ISHIKO, J
SUZUKI, M
OHTSUKI, I
[J]. JAPANESE JOURNAL OF PHARMACOLOGY, 1986, 40 : P244 - P244

← 1 2 3 4 5 →